- Home
- YORW vs CRMD Comparison
YORW vs CRMD Comparison
Compare YORW & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | YORW | CRMD |
|---|---|---|
| Founded | 1816 | 2006 |
| Country | United States | United States |
| Employees | 104 | N/A |
| Industry | Water Supply | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 472.0M | 561.8M |
| IPO Year | 1994 | 2009 |
Fundamental Metrics
Financial Performance| Metric | YORW | CRMD |
|---|---|---|
| Price | $32.27 | $6.43 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $15.14 |
| AVG Volume (30 Days) | 67.6K | ★ 1.4M |
| Earning Date | 01-01-0001 | 06-05-2026 |
| Dividend Yield | ★ 2.79% | N/A |
| EPS Growth | N/A | ★ 780.00 |
| EPS | 1.39 | ★ 2.04 |
| Revenue | $77,488,000.00 | ★ $311,709,000.00 |
| Revenue This Year | $9.74 | $1.10 |
| Revenue Next Year | $7.89 | N/A |
| P/E Ratio | $23.50 | ★ $3.15 |
| Revenue Growth | 3.37 | ★ 617.03 |
| 52 Week Low | $29.68 | $5.60 |
| 52 Week High | $36.48 | $17.43 |
Technical Indicators
Market Signals| Indicator | YORW | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 42.07 | 34.42 |
| Support Level | $31.23 | N/A |
| Resistance Level | $32.98 | $7.44 |
| Average True Range (ATR) | 0.61 | 0.28 |
| MACD | -0.07 | -0.01 |
| Stochastic Oscillator | 11.24 | 22.81 |
Price Performance
Historical ComparisonAbout YORW York Water Company (The)
The York Water Co is an investor-owned water utility company in the United States. The primary business of the company is to impound, purify to meet or exceed safe drinking water standards and distribute water. It also owns and operates three wastewater collection systems and eleven wastewater collection and treatment systems. The company operates within its franchised territory, which covers more than 57 municipalities within four counties in south-central Pennsylvania.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.